Speaker: Marc S. Raab, MD (he/him/his) – Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Speaker: Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research
Career Development
Speaker: Marc S. Raab, MD (he/him/his) – Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
### he/him/his @@@ Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research ### 1395074###Speaker###Research Team Leader and Consultant Haematologist###The Institute of Cancer Research###Speaker: Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research
###Speaker: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
Speaker: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital
Meet the Professor
Speaker: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
### @@@ Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital ### 1395133###Speaker###Assistant Professor###Brigham and Women's Hospital###Speaker: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital
### he/him/hisSpeaker: Ashutosh D. Wechalekar, MD – University College Hospital
Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
Meet the Professor
Speaker: Ashutosh D. Wechalekar, MD – University College Hospital
### @@@ Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine ### 1395067###Speaker###Director, Amyloidosis Center,### Boston University Chobanian & Avedisian School of Medicine###Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
### she/her/hersSpeaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center
Meet the Professor
Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center
###Speaker: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
Speaker: Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research
Meet the Professor
Speaker: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
### he/him/his @@@ Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research ### 1949879###Speaker###Professor and Head###Postgraduate Institute of Medical Education and Research###Speaker: Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research
###Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy
Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Meet the Professor
Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy
### she/her/hers @@@ Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA ### 1409085###Speaker###Professor of Oncology and Internal Medicine###Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA###Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
###Speaker: Lalit Kumar, MD, DM (he/him/his) – Oncology and BMT, Artemis Hospitals, Gurugram122001, India
Speaker: Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute
Meet the Professor
Speaker: Lalit Kumar, MD, DM (he/him/his) – Oncology and BMT, Artemis Hospitals, Gurugram122001, India
### he/him/his @@@ Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute ### 1395102###Speaker###Assistant Professor###Michigan State University-Karmanos Cancer Institute###Speaker: Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute
###Speaker: Nelson Leung, MD – Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
Meet the Professor
Speaker: Nelson Leung, MD – Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
###Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
General Session
Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
General Session
Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN
### he/him/his @@@ Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School ### 1395035###Co-Chair###Kraft Family Chair, Director of Basic and Correlative Science, Professor of Medicine, Harvard Medical School ###Dana-Farber Cancer Institute, Harvard Medical School###Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
###Speaker: Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele
General Session
Speaker: Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele
### he/him/hisSpeaker: Jacqueline Cloos, PhD (she/her/hers) – Amsterdam UMC, location VUMC, Cancer Center Amsterdam
General Session
Speaker: Jacqueline Cloos, PhD (she/her/hers) – Amsterdam UMC, location VUMC, Cancer Center Amsterdam
### she/her/hersSpeaker: Nicole Gormley, MD – U.S. Food and Drug Administration
General Session
Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration
###Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
General Session
Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
General Session
Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
### @@@ Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center ### 1395144###Co-Chair###Professor of Medicine, Director of Myeloma Research###NYU Langone Health Perlmutter Cancer Center###Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
### he/him/hisSpeaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA
General Session
Speaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA
### she/her/hersSpeaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University
General Session
Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University
### she/her/hersSpeaker: Felipe Prosper, MD (he/him/his) – Clinica Universidad de Navarra
General Session
Speaker: Felipe Prosper, MD (he/him/his) – Clinica Universidad de Navarra
### he/him/hisSpeaker: Arun P. Wiita, MD, PhD – University of California San Francisco, San Francisco, CA, USA
General Session
Speaker: Arun P. Wiita, MD, PhD – University of California San Francisco, San Francisco, CA, USA
###Speaker: Maximilian Merz, MD (he/him/his) – University of Leipzig
General Session
Speaker: Maximilian Merz, MD (he/him/his) – University of Leipzig
### he/him/hisSpeaker: Laura Lucia Cogrossi – San Raffaele Scientific Institute
General Session
Speaker: Laura Lucia Cogrossi – San Raffaele Scientific Institute
###Speaker: Andrea Poletti, PhD – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
General Session
Speaker: Andrea Poletti, PhD – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
###Speaker: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
General Session
Speaker: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
### he/him/hisPanelist: Sonja Zweegman, MD, PhD – Amsterdam UMC
Panelist: Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole
Panelist: Wilson I. Gonsalves, MD – Mayo Clinic, Rochester
General Session
Panelist: Sonja Zweegman, MD, PhD – Amsterdam UMC
### @@@ Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole ### 1395049###Panelist###Head###IUC-Oncopole###Panelist: Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole
### he/him/his @@@ Wilson I. Gonsalves, MD – Mayo Clinic, Rochester ### 1395132###Panelist###Consultant, Division of Hematology, Department of Internal Medicine###Mayo Clinic, Rochester###Panelist: Wilson I. Gonsalves, MD – Mayo Clinic, Rochester
###Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
Industry Symposium
Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
Industry Symposium
Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
###Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
Industry Symposium
Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
###Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
Industry Symposium
Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
###Speaker: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
Industry Symposium
Speaker: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
###Speaker: Roberto Mina, MD – European Myeloma Network, Italy
Industry Symposium
Speaker: Roberto Mina, MD – European Myeloma Network, Italy
###Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
### @@@ Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA ### 1395113###Co-Chair###Professor and Chair###Emory University School of Medicine, Atlanta, GA, USA###Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
###Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary
General Session
Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary
###Speaker: Lawrence Boise, PhD (he/him/his) – Emory University
General Session
Speaker: Lawrence Boise, PhD (he/him/his) – Emory University
### he/him/hisSpeaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
General Session
Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
### she/her/hersSpeaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra
General Session
Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra
### she/her/hersSpeaker: Shuntaro Ikegawa, MD, PhD – Dana-Farber Cancer Institute
General Session
Speaker: Shuntaro Ikegawa, MD, PhD – Dana-Farber Cancer Institute
###Speaker: Alexandra M. Poos, PhD (she/her/hers) – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg
General Session
Speaker: Alexandra M. Poos, PhD (she/her/hers) – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg
### she/her/hersSpeaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
General Session
Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
###Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
###Panelist: P. Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital
Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network
Panelist: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
Panelist: Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre
Panelist: Ajai Chari, MD, PhD – University of California, San Francisco
Panelist: Bindu Kanapuru
General Session
Panelist: P. Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital
### she/her/hers @@@ Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network ### 1395117###Panelist###Medical Director, Princess Margaret Cancer Centre and VP Cancer, University Health Network###Princess Margaret Cancer Centre, University Health Network###Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network
### @@@ MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens ### 1949885###Panelist###Professor###Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens###Panelist: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
### he/him/his @@@ Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre ### 1395149###Panelist###Professor of Medicine, Director, Clinical Trials Program for Multiple Myeloma and Related Diseases###University Health Network, Princess Margaret Cancer Centre###Panelist: Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre
### @@@ Ajai Chari, MD, PhD – University of California, San Francisco ### 1395089###Panelist###Director of Multiple Myeloma Program Professor of Clinical Medicine###University of California, San Francisco###Panelist: Ajai Chari, MD, PhD – University of California, San Francisco
### @@@ Bindu Kanapuru ### 2102754###Panelist#########Panelist: Bindu Kanapuru
###Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
Oral Abstract Session
Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
Oral Abstract Session
Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
### @@@ Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece ### 1442719###Co-Chair###Hematology Consultant###Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece###Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
### she/her/hersSpeaker: Darrell White, MD (he/him/his) – Dalhousie University and Queen Elizabeth II Health Sciences Centre
Oral Abstract Session
Speaker: Darrell White, MD (he/him/his) – Dalhousie University and Queen Elizabeth II Health Sciences Centre
### he/him/hisSpeaker: Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University
Oral Abstract Session
Speaker: Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University
###Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
Oral Abstract Session
Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
### she/her/hersSpeaker: Samer Al Hadidi, MD,MS,FACP – the University of Arkansas for Medical Sciences
Oral Abstract Session
Speaker: Samer Al Hadidi, MD,MS,FACP – the University of Arkansas for Medical Sciences
###Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes
Oral Abstract Session
Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes
###Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University
Oral Abstract Session
Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University
Oral Abstract Session
Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
### @@@ Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University ### 1395121###Co-Chair###Assistant Professor Of Medicine### Meyer Cancer Center, Weill Cornell Medicine, Cornell University###Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University
###Speaker: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA
Oral Abstract Session
Speaker: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA
###Speaker: Linda B. Baughn, PhD (she/her/hers) – Mayo Clinic, Rochester, MN, US
Oral Abstract Session
Speaker: Linda B. Baughn, PhD (she/her/hers) – Mayo Clinic, Rochester, MN, US
### she/her/hersSpeaker: Jiye Liu, PhD (he/him/his) – Dana-Farber Cancer Institute
Oral Abstract Session
Speaker: Jiye Liu, PhD (he/him/his) – Dana-Farber Cancer Institute
### he/him/hisSpeaker: Takahiro Kamiya, MD (he/him/his) – Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
Oral Abstract Session
Speaker: Takahiro Kamiya, MD (he/him/his) – Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
### he/him/hisSpeaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
Oral Abstract Session
Speaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
###